Gilead Sciences’ closely-watched COVID-19 drug candidate remdesivir outperformed placebo in a clinical trial sponsored by the NIH’s National Institute of…
Super UserMay 4, 2020
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings,…
Super UserMay 4, 2020
BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that the company has received market clearance…
Super UserApril 28, 2020
BALTIMORE, Md., April 27, 2020 /PRNewswire/ -- LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University,…
Super UserApril 28, 2020
BioHealth Innovation If you are having trouble viewing this email, please click here June 9, 2020 FOUNDING MEMBER OF Anthony…
Super UserApril 28, 2020
BioHealth Innovation If you are having trouble viewing this email, please click here June 16, 2020 FOUNDING MEMBER OF Fina…
Super UserApril 28, 2020
BioHealth Innovation If you are having trouble viewing this email, please click here June 23, 2020 FOUNDING MEMBER OF Charles…
Super UserApril 28, 2020
BioHealth Innovation If you are having trouble viewing this email, please click here April 28, 2020 FOUNDING MEMBER OF Innara…
Super UserApril 28, 2020
Gentian AS, a Norwegian company, with its US office at BioHealth Innovation in Rockville, Maryland is seeking collaborators to investigate…
Super UserApril 27, 2020